ストックスクリーナーアプリを入手
377.46
1.11%
4.16
アフターアワーズ：
375.35
-2.11
-0.56%
前日終値:
$373.30
開ける：
$369.57
24時間の取引高:
1.80M
Relative Volume:
1.34
時価総額：
$142.48B
収益：
$22.60B
当期純損益:
$2.99B
株価収益率:
48.64
EPS:
7.76
ネットキャッシュフロー:
$3.49B
1週間 パフォーマンス:
+2.63%
1か月 パフォーマンス:
-2.26%
6か月 パフォーマンス:
+6.29%
1年 パフォーマンス:
+8.04%
1日の値動き範囲:
$366.69
$378.35
1週間の範囲:
$361.02
$378.35
52週間の値動き範囲:
$314.93
$406.19
Stryker Corp Stock (SYK) Company Profile
SYK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-26 | 再開されました | Citigroup | Buy |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | 開始されました | Wolfe Research | Outperform |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-22 | アップグレード | Needham | Hold → Buy |
| 2024-01-31 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | 開始されました | ROTH MKM | Buy |
| 2023-09-05 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-25 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-28 | アップグレード | Edward Jones | Hold → Buy |
| 2022-07-21 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-07-11 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-04-13 | 開始されました | Truist | Hold |
| 2022-03-16 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | 再開されました | Evercore ISI | Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | 開始されました | Loop Capital | Buy |
| 2021-09-14 | 再開されました | Raymond James | Mkt Perform |
| 2021-07-28 | アップグレード | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-05-25 | 開始されました | Barclays | Underweight |
| 2020-10-06 | 開始されました | Northland Capital | Market Perform |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-13 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2020-04-01 | ダウングレード | Goldman | Buy → Sell |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-08 | 開始されました | SunTrust | Hold |
| 2020-01-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | 繰り返されました | BTIG Research | Buy |
| 2019-11-05 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-10-30 | 繰り返されました | BofA/Merrill | Buy |
| 2019-07-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-30 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2019-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-08-16 | 開始されました | BTIG Research | Buy |
| 2018-06-27 | 開始されました | Bernstein | Mkt Perform |
| 2018-04-27 | 繰り返されました | Stifel | Buy |
すべてを表示
Stryker Corp (SYK) 最新ニュース
Evercore ISI Adjusts Stryker Price Target to $400 From $410, Maintains Outperform Rating - MarketScreener
Stryker Closes Sale of US Spinal Implants Unit to Vascogliosi Brothers - MarketScreener
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC - Benzinga
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC - Yahoo Finance
Stryker completes sale of U.S. spinal implants business - MarketScreener
Stryker sells US spinal implants business to VB Spine - Investing.com
Stryker Completes Sale Of U.S. Spinal Implants Business - MarketScreener
Major Strategic Shift: Stryker Sells Spinal Unit While Keeping Key Tech Rights - Stock Titan
Stryker : 2024 Comprehensive Report - MarketScreener
Stryker Corporation (NYSE:SYK): One of the Best Robotics Stocks to Buy According to Billionaires - Insider Monkey
Stocks With Rising Relative Strength: Stryker - MSN
California Public Employees Retirement System Raises Stake in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker Corporation (SYK): Jim Cramer Sees Big Gains Despite Tariff Worries - Insider Monkey
Ex-Dividend Reminder: Stryker, Innovative Industrial Properties and Apple Hospitality REIT - Nasdaq
Jim Cramer: Stryker Is A 'Good' Company, Says He Likes This Utilities Stock - Benzinga
Stryker Options Trading: A Deep Dive into Market Sentiment - Benzinga
Stryker increases pay for top execs, reports slightly lower wage for median employee - Medical Design & Outsourcing
Stryker announces intention to nominate Manny Maceda to board of directors - Quantisnow
Stryker nominates new board member - Investing.com
Stryker nominates new board member By Investing.com - Investing.com Canada
Global Transformation Expert and Bain Chairman Joins Stryker's Board - Stock Titan
Is It Smart To Buy Stryker Corporation (NYSE:SYK) Before It Goes Ex-Dividend? - Yahoo Finance
Stryker announces Annual Meeting of Shareholders - Yahoo Finance
Here's How Much $1000 Invested In Stryker 5 Years Ago Would Be Worth Today - Benzinga
Stryker Makes Shareholder Meeting Accessible: Virtual Format Opens Doors to All Investors - Stock Titan
What's Driving the Market Sentiment Around Stryker? - Benzinga
Breaking Down Stryker: 13 Analysts Share Their Views - Benzinga
Needham maintains Stryker stock Buy rating, $442 target - Investing.com
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec - Yahoo Finance
New Jersey Rep. Thomas Kean Sold Over $17K Worth of Stryker Stock: Here's What You Should Know - Benzinga
Stryker : 2024 Comprehensive Report Factsheet -March 17, 2025 at 08:10 am EDT - Marketscreener.com
Thomas Kean Jr makes notable trades in Amazon, Magnera Corp, and Stryker Corp - Investing.com Australia
Spelman College Receives $30M To Help Fund New Arts Center - Essence
Stryker Unveils Next-Generation Mako SmartRobotics but Stock Falls - MSN
Stryker’s Strong Market Position and Growth Prospects Justify Buy Rating - TipRanks
Stryker Co. (NYSE:SYK) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
RBC Capital maintains Stryker stock Outperform rating, $435 target - Investing.com
RBC Capital maintains Stryker stock Outperform rating, $435 target By Investing.com - Investing.com South Africa
At US$364, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List? - Yahoo Finance
Stryker Rides Wave as New Products See Continued Adoption - Morningstar
Piper Sandler maintains $420 target on Stryker stock - Investing.com
Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting - Quantisnow
Revolutionary Upgrade: How Stryker's New Mako Robot Transforms 4 Major Surgeries - StockTitan
Stryker Stock To $300? - Nasdaq
Can SYK Stock Plunge Below $300? - Forbes
Stryker Corp (SYK) Unveils Artix Thrombectomy System for Enhanced Arterial Clot Treatment - GuruFocus.com
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases - Marketscreener.com
StockNews.com Downgrades Stryker (NYSE:SYK) to Hold - Defense World
SYK Stock Declines Despite Steri-Shield Launch to Boost OR Portfolio - Yahoo Finance
Is Stryker Stock Outperforming the S&P 500? - Nasdaq
Is Stryker Stock Outperforming The S&P 500? - Barchart
Stryker Corp (SYK) 財務データ
収益
当期純利益
現金流量
EPS
1.18%
0.42%
大文字化:
|
ボリューム (24 時間):